is the fda stopping the sale of tirzepatide moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified 📢Important FDA Update on Compounded

Compounded semaglutide is typically paid for out-of-pocket, and patients may consult their benefits provider to determine whether HSA or FSA funds can be used

Biochem researcher I switched to Woosh after a competitor's purity claim didn't hold up to third-party testing

Neurophysiol Clin

Common side effects include nausea or vomiting, constipation, bloating, diarrhea, and low energy

Tirzepatide (Mounjaro) boasts around a 20% body weight loss in a year, and with it a slew of other benefits: reduced blood pressure, improved hemoglobin A1c levels, better cholesterol

Swelling in legs, feet, or face alongside urinary changes